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E D I T O R I A L
MacGyver or Machiavellian approaches to delivery of
sevoflurane in neonates
Optimal ventilation of the sick neonate is one of the most challeng-
ing practices for anesthetists. The whole infrastructure including the
ventilator and connecting tubing in the operating room are often
suboptimal for this specific population. In addition, comprehension
of anesthesia requirements and ventilation strategies differ substan-
tially between neonatologists and anesthetists. For example, neona-
tologists are more likely to use pressure‐regulated volume control
modes and other protective ventilation modalities than anesthesiolo-
gists who prefer pressure‐ or volume‐controlled modes.1 Therefore,
maintaining a neonate on the same ventilation regimen to and from
the neonatal intensive care unit for surgery in operating room is con-
tended. In this issue of the journal, Brustal and Threlfo have
attempted a solution by offering anesthetists a possibility to adminis-
ter inhalation volatile agents within a built‐on system mounted on a
neonatal ventilator that can be used as an alternative to anesthesia
ventilators in the operating room.2 In this remarkable laboratory
bench test, they addressed in a well‐structured manner all the tech-
nical and personal challenges that arise from mounting a vaporizer
into a circuit that was not initially designed for. This systematic
approach has the merit to remind the anesthetists of all the potential
pitfalls that evolve from redesigning a ventilator circuit. Moreover,
the attention put forward to develop standard operation procedures
and training schedule for health care providers is worth commend-
ing.
Anesthetists are well known to collect bits and pieces of equip-
ment in order to adapt to weird situations where anesthesia must be
delivered. No doubt the television series, MacGyver (1985‐1992),
was popular within the anesthesia community where problem‐solving
is part of daily routine. In this regard, we can appreciate efforts for
overcoming technical issues due to the opposing requirements for
optimal neonatal ventilation and precise delivery of volatile agents.
However, established equipment used routinely in anesthesia prac-
tice are already a major source of near‐misses reported to morbidity
and mortality reviews.3 Thus, applying various sundry items, even if
they comply with standards, run the risk of causing difficulties such
as disconnection, obstruction, or misuse. In doing so, one may unin-
tentionally end up in a Machiavellian situation where patient safety
may be threatened. In addition, using the low‐pressure input as the
driving gas flow for a vaporizer may introduce uncertainties in the
real concentration delivered, since the inspiratory gas flow profile
(constant flow or decelerating flow) may exert a biasing effect. It is
not surprising that the authors found a complete discordance with
high‐frequency oscillation ventilation where inspiratory airflow was
variable.
Promoting a system based exclusively on bench testing can
cause overconfidence about the usefulness and the safety of the
system developed. Translating bench findings to clinical practice in
neonates requires more thorough clinical investigations by reporting
the physiological outcomes, such as respiratory mechanics, proof for
optimal gas exchange, and accuracy and stability of sevoflurane
delivery over a prolonged time. Furthermore, while the authors have
paid attention to scavenging, the issue of waste gas is not yet
addressed in a satisfactory way. First, there is a lack of proper quan-
tification of the sevoflurane concentration in the environment
despite stating lack of detectability “close and within the exhalation
valve cowl.” Moreover, the scavenging issue has not been clarified
during transportation of the patient where no suction may be avail-
able for waste gas removal. Accordingly, there is a remaining concern
about the environmental concentration of exhaled sevoflurane,
which may cause harm for health care providers.4,5 Provision of
sevoflurane in an open‐circuit with high gas flow is not without an
additional challenge. The targeted alveolar gas concentration can be
readily achieved by such a system but at the expense of high con-
sumption and waste of sevoflurane. This feature explains the lack of
implementation of vaporizers on ventilators used in pediatric inten-
sive care units and the search for alternative techniques to provide
these volatile agents.6
A major question for pediatric anesthesiologists is about the
use of sevoflurane‐based anesthesia in neonates. During the last
decade a real concern has arisen about the potential neurotoxic-
ity of anesthetic agents.7,8 While no evidence for an effect on
neurodevelopment could be demonstrated following short dura-
tion surgical procedures with sevoflurane,9 the use of this volatile
agent was associated with lower blood pressures that could
potentially jeopardize cerebral blood flow.10 Moreover, neonates
show limited changes in the electroencephalogram pattern with
variations in sevoflurane concentrations used in clinical practice,
which may lead to its overdosing with subsequent potential for
burst suppression and inability to assess cerebral activity.11
Therefore, delivering sevoflurane in neonates without the applica-
tion of cerebral monitoring (eg, near intra‐red spectroscopy) is
like being in the eye of a storm where you have no idea about
the subsequent hemodynamic consequences. Consequently,
sevoflurane delivery during transportation, a well‐established
phase of potential instability, exposes the neonate to a greater
risk of hypotension and alterations in the microcirculation. Opi-
oid‐based anesthesia in critically ill premature babies and neo-
nates, a technique that allows better hemodynamic stability and
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enables anesthesia management without the need for volatile
agents, is promoted above inhalational agents.
Applying new techniques and ventilation strategies in neonates
requires strong evidence of both their harmlessness and usefulness.
While the highly interesting and well‐designed bench test presented
in this issue may be a first step in the intellectual process for
improving patient management, there is a need for further measures
in laboratory investigations and clinical settings before promoting
their values. While anesthesiologists are famous for applying MacGy-
ver “do‐it‐yourself” approaches, involvement of professional devel-
opers from ventilator industry would avoid to slide toward a near‐
misses situation.
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